Science Education
>

Mechanical Conflict-Avoidance Assay to Measure Pain Behavior in Mice

Instructor Prep
concepts
Student Protocol
JoVE Journal
Neuroscience
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Neuroscience
Mechanical Conflict-Avoidance Assay to Measure Pain Behavior in Mice

All experiments involving the use of mice and the procedures followed therein were approved by Institutional Animal Care and Use Committees of MD Anderson Cancer Center and Stanford University, in strict accordance with the National Institutes of Health’s Guide for the Care and Use of Laboratory Animals.

1. MCA construction

  1. Construct chamber 1 with the following dimensions: 125 mm x 125 mm x 125 mm (width x depth x height) from opaque white 3 mm thick acrylic used for the sidewalls, floor, ceiling. Use a clear 3 mm thick acrylic for the front-facing wall. Glue all sides together well in advance using dedicated acrylic adhesive.
    CAUTION: Acrylic adhesive is considered hazardous material (flammable, vapor harmful, may be harmful if swallowed, may irritate skin or eyes). Such adhesives should only be used in accordance with the manufacturer's instructions (i.e., with appropriate PPE in a well-ventilated area).
  2. Attach the lid of chamber 1 with a hinge, so that mice can be easily placed into and retrieved from the chamber. Attach self-adhesive light-emitting diode (LED) tape to the inner surface of the lid to provide illumination of ~4800 lux.
  3. Close off chamber 1 from the rest of the MCA by sliding an opaque acrylic sheet into and out of position.
  4. Construct the MCA test chamber, chamber 2, as a 270 mm long unlit chamber fabricated from translucent dark red acrylic (3 mm thick) on all sides, with a hinged lid on top. Place a 13 x 31 grid of 2 mm holes on the floor of chamber 2 through which an array of blunt probes with 0.5 mm diameter tips (e.g., blunted map pins) can protrude.
    NOTE: Blunt pins with a 120-grit sandpaper block or similar. Clean them in warm water with detergent before being disinfected with sporicidal disinfectant.
  5. Adjust the height of the probes by placing additional acrylic sheets beneath the probe baseplate (Figure 1). Using this approach, configure the device with three settings: 0 mm, 2 mm, and 5 mm probe height.
  6. As an alternative to blunted map pins or similar materials, use the 3D printer files to print the floor of chamber 2 and the probe plate (see Supplementary File 1: SpikeBed-MCA.stl which refers to the mechanical probes, and Supplementary File 2: MCA_baseplate.stl which forms the floor of chamber 2).
    NOTE: If 3D printing is not available, glue map pins to an acrylic sheet using the same acrylic adhesive used to construct the walls of the device.
  7. Print with a washable and biocompatible material, such as nylon 12 plastic or similar (recommended).
  8. Construct chamber 3 with the following dimensions: 125 mm x 125 mm x 125 mm as an unlit translucent dark red acrylic box (on all sides), placed at the opposite end to chamber 1. Place a hinged lid on the chamber, similar to chambers 1 and 2. This chamber serves as a darkened escape area from the mechanical probes in chamber 2.

2. Mouse MCA habituation and testing

  1. As with all experiments involving behavioral outcomes in animals, observe appropriate randomization and blinding throughout to minimize potential bias.
    NOTE: The representative results were generated by using 8-12 week old male and female C57BL/6J mice (Jackson Laboratories strain number 000664). Mice were socially housed, up to 5 per cage, with access to food and water ad libitum and a 07:00 h to 19:00 h light cycle. MCA took place in the light period, between 09:00 h and 12:00 h.
  2. One day before baseline testing is scheduled, acclimate mice to the MCA unit for 5 min (minimum) to 15 min (maximum) with their cage mates to facilitate social exploration of the entire device.
  3. Throughout the process, ensure that the LEDs in chamber 1 are switched off, the barrier between chambers 1 and 2 is left open, and the probes are set to a height of zero (i.e., not protruding through the floor of chamber 2).
  4. Perform a baseline test of mice (optional) if the study incorporates negative control animals (i.e., sham surgery, or vehicle injection controls). If desired, use a baseline test to exclude any uninjured outliers that never cross into chamber 2, though this has not proven necessary. If used, report all criteria for exclusion and the number of mice excluded.
    1. Before beginning testing, set up a video camera capable of recording 1080p footage on a tripod with a side-facing view of the entire MCA device. Adjust the field of view such that the MCA fills the recorded image.
    2. Once recording begins, hold a handheld dry-erase board in the camera's field of view to label the start of the video with identifying information on the animal's testing run (e.g., mouse ID, probe height, date, time point, etc.).
    3. For the first run, set the probe height to zero. Transfer the mouse to be tested from its home cage to chamber 1 with the barrier door in place. Start a timer that is visible in the recorded footage.
      NOTE: The timer ensures that the intervals between the different parts of the test are consistent between runs.
    4. After 10 s, switch on the chamber 1 LEDs. After the mouse has been in the lit chamber for 20 s, withdraw the barrier between chambers 1 and 2.
    5. Observe the animal for 2 min. Measure latencies and/or dwell times with a stopwatch while the test is ongoing. Alternatively, the video footage can be analyzed once testing is complete.
      NOTE: For reasons of throughput and avoiding prolonged exposure to aversive stimuli, the cutoff was set at 2 min.
    6. Measure one or more of the several useful outcomes that have been identified (see below; Figure 1). Recommended to analyzie all 5 outcome measures when beginning testing, in order to ascertain which aspects of behavior differ in a given experimental setup.
      1. Option I: Record the latency to the first entry to chamber 2. Option II: Record the latency to crossing more than halfway across chamber 2. Option III: Record the total dwell time in chamber 2. Option IV: Record the latency to reach chamber 3 (escape). Option V: Similar to option II, record the total dwell time in each chamber within 2 min and convert them into proportions.
        NOTE: Since every experiment is unique and may be influenced by biological factors and behavioral changes unique to the disease model, investigators can experiment with these and other measures in their own hands.
    7. Once testing is complete, return the mouse to its home cage, clean the MCA chambers with 70% ethanol, and allow it to dry completely.
      NOTE: Fecal boli can usually be cleaned from the chamber relatively easily with paper towels prior to ethanol/disinfectant. If more thorough cleaning becomes necessary, chambers 2 and 3 can be disassembled and immersed in warm, soapy water.
    8. After running all mice in a cohort with the probe height set to zero, insert a 3 mm sheet of acrylic beneath the mechanical probe baseplate and repeat steps 2.4.2 to 2.4.7 with a probe height of 2 mm.
    9. After running all mice with the probe height set to 2 mm, insert a second 3 mm sheet of acrylic beneath the probe base plate and repeat steps 2.4.2 to 2.4.7 with a probe height of 5 mm.
      NOTE: A group of 8 mice can be tested in approximately 2 h using this approach. Use smaller group sizes if more precise post-drug timing is required (e.g., for a drug time course experiment).
    10. Perform a final cleaning with a disinfectant at the end of a testing session.
  5. Repeat testing after inducing pain hypersensitivity and/or with drug treatment.
  6. Compare each mouse's performance at baseline with their performance after the pain is induced. Assess the impact of a pharmacological intervention by comparing vehicle-treated animals with drug-treated animals at the same timepoint.
  7. Perform non-parametric statistical analysis (e.g., the Mann Whitney U Test) if animals reach the 2 min cutoff without satisfying the desired outcome measure, resulting in non-continuous data.

Mechanical Conflict-Avoidance Assay to Measure Pain Behavior in Mice

Learning Objectives

The MCA assay has been used successfully with several mechanistically distinct mouse pain models. Figure 2 shows data where the outcome measure of choice was crossing the mid-point of chamber 2 (Figure 2A). The data obtained by using the halfway point versus escape into chamber 3 are very similar, ~40 s for halfway versus ~45 s for chamber 3 escape in the spared nerve injury (SNI) model of neuropathic pain with 5 mm probe height13.

In the CFA-induced inflammatory pain model, control hind paw (intraplantar) injection of saline does not change escape latency versus baseline. Those mice that were injected with CFA in one hind paw showed a significant increase in escape latency 4 days post-injection, but only when the probe height was raised to 5 mm. Crucially, this increased latency to escape at 5 mm was not seen in mice that received the NSAID carprofen (10 mg/kg, i.p.) 90 min before the beginning of testing (Figure 2B).

The spared nerve injury (SNI) model of traumatic neuropathic pain, is also associated with a significant increase in the latency to escape versus baseline when probe height was set to 5 mm. This effect was seen in SNI mice, but not their sham surgery controls. This increased escape latency was also prevented by systemic administration of the opioid analgesic buprenorphine (25 µg/kg, i.p.) 90 min prior to testing (Figure 2C). Increased escape latency was also observed in mice that did not undergo a baseline round of MCA testing prior to nerve injury (Figure 2D). In this case, the increased escape latency in SNI mice at 5 mm was prevented by gabapentin (30 mg/kg, i.p.) administered 90 min prior to testing. Collectively, this suggests that MCA can detect pain-related changes in stimulus aversion and avoidance in two widely-used models of inflammatory and neuropathic pain.

MCA was further tested in the fracture/casting model of the chronic pain condition complex regional pain syndrome (CRPS) which is established by a closed right distal tibia fracture followed by 3 weeks of casting14. This clinically informed model exhibits acute phase peripheral inflammation, as well as long-term immune activity in the central nervous system with persistent hindlimb allodynia. Similar to the CFA and SNI models, increased escape latencies were observed in the fracture/casting model (Figure 3A). Prior to the injury, the latency to escape from chamber 1 increased proportionally to the probe height. After the injury, the escape latency remained unchanged at 0 mm but significantly increased at the 2 mm and 5 mm probe height for males and the 5 mm probe height for females when compared to baseline (Figure 3B).

Figure 1
Figure 1: Schematic and images of the MCA device. (A) Potential outcome measures in the MCA assay, (marked by clockface icons): latency to exit chamber 1 (I), latency to cross more than 50% of chamber 2 (dotted line; II), the total amount of time spent in chamber 2 (III), latency to reach the escape chamber (IV) or percent time spent in each chamber (V). Animals experiencing pain on average show greater values for I, II, and IV, and reduced values for III. A reduced value for III necessarily increases the proportion of time spent in chamber 1 and/or chamber 3, which would be captured by outcome measure V. Created with Biorender.com. (B) Images illustrating the MCA device (and chambers numbered 1, 2, and 3) with the LEDs switched off (top left), the LEDs switched on (bottom left). (C) A view of the chambers from above with the doors opened. Please click here to view a larger version of this figure.

Figure 2
Figure 2: Inflammatory and neuropathic pain augment avoidance in the MCA assay. (A) Depiction of the specific outcome measure used here: latency to cross the chamber 2 midpoint. (B) Intraplantar injection of CFA significantly increased the latency to escape (red squares) versus saline controls (black circles) when the probe height was set to 5 mm. Intraperitoneal carprofen (10 mg/kg) attenuated the CFA-induced increase in escape latency (blue triangles). Data are plotted as mean escape latency ± standard error of the mean (SEM); n = 7 males/group. (C) Spared nerve injury (SNI) surgery significantly increased chamber 1 escape latency versus sham surgery controls (black circles), when probe height was set to 5 mm (red squares). Intraperitoneal buprenorphine (25 mg/kg) significantly attenuated this increase in escape latency (blue triangles). Data are plotted as mean escape latency ± SEM; n = 6-7 males per group. (D) SNI-induced increase in escape latency was reversed by use of the analgesic gabapentin (green triangles). Data are plotted as mean escape latency ± SEM; n = 8 males/group. ## = p < 0.01, ***/### = p < .001, for the indicated comparisons (two-way ANOVA, Bonferroni post-hoc). This figure has been modified from13. Please click here to view a larger version of this figure.

Figure 3
Figure 3: Tibial fracture/casting induced chronic pain augment avoidance in the MCA assay. Fracture/casting significantly increased escape latency at 3 weeks post-injury (W3) versus baseline (BL) in males at the 2 mm and 5 mm probe heights and in females at the 5 mm probe height (n = 5/sex). Data from each mouse are depicted in faded black (males) or cayenne (females) with mean represented by dark lines. **/*** = p < 0.01/< 0.001 versus sex- and probe height-matched baseline value by two-way ANOVA, Tukey post-hoc. Please click here to view a larger version of this figure.

Supplementary File 1: 3D printer file SpikeBed-MCA. When printed in a suitably biocompatible and washable material, such as nylon 12, SpikeBed-MCA.stl produces the platform of tactile probes which protrude through the floor of chamber 2. Please click here to download this File.

Supplementary File 2: 3D Printer file MCA_baseplate. When printed in a suitably biocompatible and washable material, such as nylon 12, MCA_baseplate.stl produces the floor of chamber 2, through which the tactile probes protrude. Please click here to download this File.

List of Materials

32.8ft 3000K-6000K Tunable White LED Strip Lights, Dimmable Super Bright LED Tape Lights with 600 SMD 2835 LEDs Lepro SKU: 410087-DWW-US For lighting chamber 1. https://www.lepro.com/32ft-dimmable-tunable-white-led-strip-lights.html
3D printed 'spike bed' and 'chamber 2 floor' Shapeways N/A Optional, for mechanical probes as an alternative to blunted map pins.
70% ethanol Various N/A To clean MCA between mice.
Acryl-Hinge 2 TAP Plastics N/A for attaching chamber lids to rear walls. https://www.tapplastics.com/product/plastics/handles_hinges_latches/acryl_hinge_2/122
Chemcast Cast Acrylic Sheet, Clear TAP Plastics N/A 3mm thick. For front wall of chamber 1. https://www.tapplastics.com/product/plastics/cut_to_size_plastic/acrylic_sheets_cast_clear/510
Chemcast Cast Transparent Colored Acrylic, Transparent Dark Red – 50% TAP Plastics N/A 3mm thick. 50% light transmission. For walls and lids of chambers 2 and 3. https://www.tapplastics.com/product/plastics/cut_to_size_plastic/acrylic_sheets_transparent_colors/519
Chemcast Translucent & Opaque Colored Cast Acrylic, Sign Opaque White – 0.1% TAP Plastics N/A 3mm thick. For side walls and lid of chamber 1. https://www.tapplastics.com/product/plastics/cut_to_size_plastic/acrylic_sheets_color/341
Disinfectant (e.g. Quatricide) Pharmacal Research Laboratories, Inc. 65020F To disinfect MCA at the end of a testing session.
Dry-erase markers and board Various N/A To add experimental info to the beginning of video footage.
Map pins Various N/A Optional, for mechanical probes. Use sandpaper to blunt sharp points before use. Can be used in place of 3D-printed parts.
Paper towels Various N/A To clean/disinfect MCA.
SCIGRIP Weld-On #3 Acrylic Cement TAP Plastics N/A For assembling acrylic sheets into chambers and affixing hinges. https://www.tapplastics.com/product/repair_products/plastic_adhesives/weld_on_3_cement/131
Stopwatch Various N/A To record escape latencies/dwell times in real-time or from recorded video.
Timer Various N/A To ensure LED turn-on, barrier removal and test completion are timed consistently.
Video camera Various HDRCX405 Handycam Camcorder To record mouse behavior in the MCA device. Can be substituted with any consumer-grade video camera capable of 1080p resolution.
Tripod Famall N/A Any tripod that can hold the camera at bench height for recording MCA footage is acceptable.

Lab Prep

Pain comprises of both sensory (nociceptive) and affective (unpleasant) dimensions. In preclinical models, pain has traditionally been assessed using reflexive tests that allow inferences regarding pain’s nociceptive component but provide little information about the affective or motivational component of pain. Developing tests that capture these components of pain are therefore translationally important. Hence, researchers need to use non-reflexive behavioral assays to study pain perception at that level. Mechanical conflict-avoidance (MCA) is an established voluntary non-reflexive behavior assay, for studying motivational responses to a noxious mechanical stimulus in a 3 chamber paradigm. A change in a mouse’s location preference, when faced with competing noxious stimuli, is used to infer the perceived unpleasantness of bright light versus tactile stimulation of the paws. This protocol outlines a modified version of the MCA assay which pain researchers can use to understand affective-motivational responses in a variety of mouse pain models. Though not specifically described here, our example MCA data use the intraplantar complete Freund’s adjuvant (CFA), spared nerve injury (SNI), and a fracture/casting model as pain models to illustrate the MCA procedure.

Pain comprises of both sensory (nociceptive) and affective (unpleasant) dimensions. In preclinical models, pain has traditionally been assessed using reflexive tests that allow inferences regarding pain’s nociceptive component but provide little information about the affective or motivational component of pain. Developing tests that capture these components of pain are therefore translationally important. Hence, researchers need to use non-reflexive behavioral assays to study pain perception at that level. Mechanical conflict-avoidance (MCA) is an established voluntary non-reflexive behavior assay, for studying motivational responses to a noxious mechanical stimulus in a 3 chamber paradigm. A change in a mouse’s location preference, when faced with competing noxious stimuli, is used to infer the perceived unpleasantness of bright light versus tactile stimulation of the paws. This protocol outlines a modified version of the MCA assay which pain researchers can use to understand affective-motivational responses in a variety of mouse pain models. Though not specifically described here, our example MCA data use the intraplantar complete Freund’s adjuvant (CFA), spared nerve injury (SNI), and a fracture/casting model as pain models to illustrate the MCA procedure.

Procedure

Pain comprises of both sensory (nociceptive) and affective (unpleasant) dimensions. In preclinical models, pain has traditionally been assessed using reflexive tests that allow inferences regarding pain’s nociceptive component but provide little information about the affective or motivational component of pain. Developing tests that capture these components of pain are therefore translationally important. Hence, researchers need to use non-reflexive behavioral assays to study pain perception at that level. Mechanical conflict-avoidance (MCA) is an established voluntary non-reflexive behavior assay, for studying motivational responses to a noxious mechanical stimulus in a 3 chamber paradigm. A change in a mouse’s location preference, when faced with competing noxious stimuli, is used to infer the perceived unpleasantness of bright light versus tactile stimulation of the paws. This protocol outlines a modified version of the MCA assay which pain researchers can use to understand affective-motivational responses in a variety of mouse pain models. Though not specifically described here, our example MCA data use the intraplantar complete Freund’s adjuvant (CFA), spared nerve injury (SNI), and a fracture/casting model as pain models to illustrate the MCA procedure.

Tags